Clinical trial
Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in…
NCT00342628 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00342628 |
|---|---|
| Title | Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants |
| Official title | Evaluation of the Safety, Immunogenicity and Compatibility With DTP of an Investigational Vi-rEPA Conjugate Vaccine for Typhoid Fever When Administered to Infants in Vietnam Concurrently With DTP |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Typhoid Fever |
| Intervention type | Biological |
| Interventions | Vi-rEPA conjugate vaccine for typhoid fever, Hib-TT, DTP |
| Enrollment | 301 |
| Start date | Jul 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Jan 1, 2011 |
| First posted | Jun 21, 2006 |
| Last update posted | Jun 27, 2012 |
| Countries | Vietnam |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: